Should you try an off-label GLP-1? StuffGray-Market Retatrutide: Less Weight Loss, More CV Effects MedscapeUnapproved obesity drug spawns a black market frenzy AxiosEli Lilly (LLY) Is Suing Six Companies Over an Unapproved Drug—Leaving Novo Nordisk (NVO) Clear in the GLP-1 Wars Yahoo FinanceInspectorate bans online dealer from illegally selling diabetes meds for weight loss NL Times
